Concise Minutes - Health, Social Care and Sport Committee

Meeting Venue:

Committee Room 1 - Senedd

Meeting date: Thursday, 5 October 2017

Meeting time: 09.31 - 14.06
This meeting can be viewed
on Senedd TV at:
http://senedd.tv/en/4410

------

Attendance

Category	Names
Assembly Members:	Dai Lloyd AM (Chair) Jayne Bryant AM Dawn Bowden AM Rhun ap Iorwerth AM Caroline Jones AM Julie Morgan AM Lynne Neagle AM
Witnesses:	Michaela Morris, Public Health Wales Rhiannon Davies, Public Health Wales Dr Victor Aziz, Royal College of Psychiatrists Dr Jane Fenton-May, Royal College of General Practitioners Dr Premini Balasekaran, Royal College of General Practitioners Alison Davies, Royal College of Nursing Wales Helen Bennett, Royal College of Nursing Wales Mair Davies, Royal Pharmaceutical Society Wendy Davies, Royal Pharmaceutical Society Steve Simmonds, Community Pharmacy Wales Sam Fisher, Community Pharmacy Wales Dr Ian James, British Psychological Society Dr Carolien Lamers, British Psychological Society
Committee Staff:	Claire Morris (Second Clerk) Sarah Sargent (Deputy Clerk) Amy Clifton (Researcher)

<AI1>

1 Introductions, apologies, substitutions and declarations of interest

1.1 The Chair welcomed Members to the meeting.

1.2 Apologies were received from Angela Burns AM.

</AI1>

<AI2>

2 Use of antipsychotic medication in care homes - evidence session 4 - Public Health Wales NHS Trust

2.1 The Committee received evidence from representatives of Public Health Wales NHS Trust.

</AI2>

<AI3>

3 Use of antipsychotic medication in care homes - evidence session 5 - Royal College of Psychiatrists and Royal College of General Practitioners

3.1 The Committee received evidence from representatives of the Royal College of Psychiatrists and the Royal College of General Practitioners.

</AI3>

<AI4>

4 Use of antipsychotic medication in care homes - evidence session 6 - Royal College of Nursing

4.1 The Committee received evidence from representatives of the Royal College of Nursing.

</AI4>

<AI5>

5 Use of antipsychotic medication in care homes - evidence session 7 - Royal Pharmaceutical Society and Community Pharmacy Wales

5.1 The Committee received evidence from representatives of the Royal Pharmaceutical Society and Community Pharmacy Wales.

5.2 The Royal Pharmaceutical Society and Community Pharmacy Wales agreed to provide additional evidence.

</AI5>

<AI6>

6 Use of antipsychotic medication in care homes - evidence session 8 - British Psychological Society

6.1 The Committee received evidence from representatives of the British Psychological Society.

</AI6>

<AI7>

7 Paper(s) to note

</AI7>

<AI8>

7.1 Inquiry into the use of antipsychotic medication in care homes - note of session on 21 September 2017

7.1a The Committee noted the note of the private session on 21 September 2017.

</AI8>

<AI9>

8 Motion under Standing Order 17.42 to resolve to exclude the public from the remainder of the meeting

8.1 The Committee agreed the motion.

</AI9>

<AI10>

9 Use of antipsychotic medication in care homes - consideration of evidence

9.1 The Committee considered the evidence given during items 2, 3, 4, 5 and 6 of the meeting.

</AI10>

<AI11>

10 Inquiry into loneliness and isolation - consideration of draft report

10.1 The Committee agreed to defer the consideration of the draft report until it’s meeting on 11 October 2017.

</AI11>

<TRAILER_SECTION>

</TRAILER_SECTION>

<LAYOUT_SECTION>

1.FIELD_TITLE

FIELD_SUMMARY

</LAYOUT_SECTION>

<TITLE_ONLY_LAYOUT_SECTION>

2.FIELD_TITLE

</TITLE_ONLY_LAYOUT_SECTION>

<HEADING_LAYOUT_SECTION>

FIELD_TITLE

</HEADING_LAYOUT_SECTION>

<TITLED_COMMENT_LAYOUT_SECTION>

FIELD_TITLE

FIELD_SUMMARY

</TITLED_COMMENT_LAYOUT_SECTION>

<COMMENT_LAYOUT_SECTION>

FIELD_SUMMARY

</COMMENT_LAYOUT_SECTION>

<SUBNUMBER_LAYOUT_SECTION>

2.1FIELD_TITLE

FIELD_SUMMARY

</SUBNUMBER_LAYOUT_SECTION>

<TITLE_ONLY_SUBNUMBER_LAYOUT_SECTION>

2.2FIELD_TITLE

</TITLE_ONLY_SUBNUMBER_LAYOUT_SECTION>